Barbara Mroczkowski

4k citations
27 papers · 3.4k · 3 hit papers · h-index 19

Impact in

Papers in

    • Signaling Pathways in Disease 2
    • RNA and protein synthesis mechanisms 2
    • Viral Infectious Diseases and Gene Expression in Insects 2
    • Ubiquitin and proteasome pathways 2
    • Angiogenesis and VEGF in Cancer 2
    • HER2/EGFR in Cancer Research 6

Barbara Mroczkowski

27 papers receiving 3.3k citations

Barbara Mroczkowski's Hit Papers

Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal–Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK) 2011 · 811 citations
8110+6+12Years since publication250500750

Peers

Barbara Mroczkowski
Comparison fields: 5 of 93
  • Structural Biology 75
  • Pulmonary and Respiratory Medicine 1k
  • Computational Theory and Mathematics 296
  • Pathology and Forensic Medicine 300
  • Molecular Biology 1k
Replace Guy P. A. Vigers with:
Guy P. A. Vigers United States
Arturo P. Galvani Italy
Monica Rosaria Maiello Italy
Joan M. Carboni United States
David C. Dalgarno United States
James Y. Tsai United States
Hetal Patel United Kingdom
Pierre‐Yves Michellys United States
Dario Ballinari Italy
Guido R. Hartmann Switzerland
Barbara Mroczkowski relative to Guy P. A. Vigers United States Guy P. A. Vigers's profile →
Citations per field
00.5×2×3×3.8×
Guy P. A. Vigers · 1×
Citations per year

Countries citing papers authored by Barbara Mroczkowski

Since Specialization
Citations

This map shows the geographic impact of Barbara Mroczkowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Mroczkowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Mroczkowski more than expected).

Fields of papers citing papers by Barbara Mroczkowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Mroczkowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Mroczkowski. The network helps show where Barbara Mroczkowski may publish in the future.

Co-authors

The 25 scholars most cited alongside Barbara Mroczkowski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Barbara Mroczkowski Line = papers co-authored together Barbara Mroczkowski links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal–Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK)
Hit paper breakdown →
2011811
2
An Orally Available Small-Molecule Inhibitor of c-Met, PF-2341066, Exhibits Cytoreductive Antitumor Efficacy through Antiproliferative and Antiangiogenic Mechanisms
Hit paper breakdown →
2007648
3
Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma
Hit paper breakdown →
2007561
4 2016287
5 1986192
6 1999181
7 1989110
8 200999
9 200879
10 199863
11 198853
12 199953
13 198452
14 198350
15 199339
16 198835
17
Growth factors in the regenerating pancreas of gamma-interferon transgenic mice.
199634
18 199429
19 200719
20 19909

About Barbara Mroczkowski

Barbara Mroczkowski is a scholar working on Molecular Biology, Oncology, Pathology and Forensic Medicine, Computational Theory and Mathematics and Structural Biology, having authored 27 papers that have together received 3.4k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (6 papers), Signaling Pathways in Disease (2 papers), RNA and protein synthesis mechanisms (2 papers), Pancreatic function and diabetes (2 papers), Synthesis and biological activity (2 papers), Viral Infectious Diseases and Gene Expression in Insects (2 papers), Ubiquitin and proteasome pathways (2 papers) and Angiogenesis and VEGF in Cancer (2 papers). The work is most often cited by research in Structural Biology (75 citations), Pulmonary and Respiratory Medicine (1k citations), Computational Theory and Mathematics (296 citations), Pathology and Forensic Medicine (300 citations) and Molecular Biology (1k citations). Barbara Mroczkowski has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Gerrit Los, Gordon Alton, Maria E. Arango, Helen Y. Zou, James G. Christensen, Scott R. P. McDonnell, Qiuhua Li, Shinji Yamazaki, Joseph Hyungwoo Lee and Stanley Cohen. Their work appears in journals such as Biochemistry, Molecular Cancer Therapeutics, Journal of Biological Chemistry, Methods in enzymology on CD-ROM/Methods in enzymology and Nature.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact